<?xml version="1.0" encoding="UTF-8"?>
<p>We assumed that an infected human passes to the exposed stage, 
 <italic>E</italic>, and, after approximately 
 <italic>ω</italic> days, becomes infectious, 
 <italic>I</italic> [
 <xref rid="pone.0174293.ref036" ref-type="bibr">36</xref>, 
 <xref rid="pone.0174293.ref038" ref-type="bibr">38</xref>, 
 <xref rid="pone.0174293.ref040" ref-type="bibr">40</xref>–
 <xref rid="pone.0174293.ref042" ref-type="bibr">42</xref>]. We followed previous modelling approaches [
 <xref rid="pone.0174293.ref040" ref-type="bibr">40</xref>, 
 <xref rid="pone.0174293.ref046" ref-type="bibr">46</xref>–
 <xref rid="pone.0174293.ref049" ref-type="bibr">49</xref>] by assuming that an infection is captured by a surveillance system with a certain probability, 
 <italic>α</italic>
 <sub>
  <italic>η</italic>
 </sub>, whereby a person becomes infectious and thus symptomatic. The infectious stage lasts approximately 
 <italic>γ</italic> days, and is either followed by recovery, 
 <italic>R</italic> [
 <xref rid="pone.0174293.ref038" ref-type="bibr">38</xref>, 
 <xref rid="pone.0174293.ref040" ref-type="bibr">40</xref>, 
 <xref rid="pone.0174293.ref041" ref-type="bibr">41</xref>, 
 <xref rid="pone.0174293.ref043" ref-type="bibr">43</xref>], or progression to the chronic stage, 
 <italic>C</italic> [
 <xref rid="pone.0174293.ref057" ref-type="bibr">57</xref>–
 <xref rid="pone.0174293.ref059" ref-type="bibr">59</xref>]. We defined fixed daily probabilities, 
 <italic>p</italic>
 <sub>
  <italic>R</italic>
 </sub> and 
 <italic>p</italic>
 <sub>
  <italic>C</italic>
 </sub>, respectively, for each of these routes.
</p>
